The shifting dynamics of pneumococcal invasive disease after the introduction of the pneumococcal 7-valent conjugated vaccine: Toward the new pneumococcal conjugated vaccines

Clinical Infectious Diseases

Volumn 49, Issue 2, 2009, Pages 213-215

  Greenberg, David ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ACUTE OTITIS MEDIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL TRANSMISSION; COMMUNITY ACQUIRED PNEUMONIA; DRUG CONJUGATION; GROUPS BY AGE; HUMAN; MORBIDITY; NOTE; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; SEROTYPE; VACCINATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BACTERIAL TYPING TECHNIQUES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PROSPECTIVE STUDIES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 67651124639     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/599828     Document Type: Note

References (25)

1. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348: 1737-46.
2. Lepoutre A, Varon E, Georges S, Guttman L, Levy-Bruhl D. Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006. Euro Surveill 2008; 13:18962. Available at: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId= 18962.
3. Vestrheim DF, Lovoll O, Aaberge IS, et al. Effectiveness of a 2+1 dose schedule pneumo- coccal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vaccine 2008;26:3277-81.
4. Tsai CJ, Griffin MR, Nuorti JP, Grijalva CG. Changing epidemiology of pneumococcal meningitis after the introduction of pneu- mococcal conjugate vaccine in the United States. Clin Infect Dis 2008;46:1664-72.
5. Grijalva CG, Nuorti JP, Arbogast PG, Martin SW, Edwards KM, Griffin MR. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 2007;369:1179-86.
6. Zhou F, Shefer A, Kong Y, Nuorti JP. Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004. Pediatrics2008; 121:253-60.
7. Black S, Shinefield H, Baxter R, et al. Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults. Vaccine 2006; 24(Suppl 2):S79-80.
8. Lexau CA, Lynfield R, Danila R, et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005;294:2043-51.
9. Centers for Disease Control and Prevention. Direct and indirect effects of routine vaccination of children with 7-valent pneumo- coccal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005; 54:893-7.
10. Kellner JD, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GJ, Scheifele DW. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-Area Streptococcus pneumoniae Research (CASPER) Study. Clin Infect Dis 2009;49:205-12 (in this issue).
11. Roche PW, Krause V, Cook H, et al. Invasive pneumococcal disease in Australia, 2006. Commun Dis Intell 2008; 32:18-30.
12. Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R. Site-specific disease potential of individual Streptococcus pneumoniae se- rotypes in pediatric invasive disease, acute oti- tis media and acute conjunctivitis. Pediatr Infect Dis J 2006; 25:602-7.
13. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 2003; 187:1424-32.
14. Dagan R, Gradstein S, Belmaker I, et al. An outbreakofStreptococcuspneumoniaeserotype 1 in a closed community in southern Israel. Clin Infect Dis 2000;30:319-21.
15. Romney MG, Hull MW, Gustafson R, et al. Large community outbreak of Streptococcus pneumoniae serotype 5 invasive infection in an impoverished, urban population. Clin Infect Dis 2008; 47:768-74.
16. Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused bynon- vaccine serotypes among alaska native children with high levels of 7-valent pneumococ- cal conjugate vaccine coverage. JAMA 2007;297:1784-92.
17. Lacapa R, Bliss SJ, Larzelere-Hinton F, et al. Changing epidemiology of invasive pneu- mococcal disease among White Mountain Apache persons in the era of the pneumo- coccal conjugate vaccine. Clin Infect Dis 2008; 47:476-84.
18. Choi E, Kim S, Eun B, et al. Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis 2008; 14:275-81.
19. Fenoll A, Granizo J, Aguilar L, et al. Trends of most prevalent serotypes not included in the 7-valent conjugate vaccine among invasive pneumococci in Spain over the last 29 years (1979-2007) [abstract P3-044]. In: Program and abstracts of the 6th International Symposium on Pneumococci and Pneumococcal Diseases (Reykjavik, Iceland). 2008:304.
20. Greenberg D, Broides A, Blancovich I, Peled N, Givon-Lavi N, Dagan R. Relative importance of nasopharyngeal versus oropharyn- geal sampling for isolation of Streptococcus pneumoniae and Haemophilus influenzae from healthy and sick individuals varies with age. J Clin Microbiol 2004; 42:4604-9.
21. Dagan R, Givon-Lavi N, Leibovitz E, Green- berg D, Porat N. Introduction and proliferation ofmultidrug-resistant Streptococcus pneu- moniae Serotype 19A clones that cause acute otitis media in an unvaccinated population. J Infect Dis 2009; 199:776-85.
22. Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA 2007;298:1772-8.
23. Hoge CW, Reichler MR, Dominguez EA, et al. An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. N Engl J Med 1994;331:643-8.
24. Vanderkooi OG, Low DE, Green K, Powis JE, McGeer A. Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 2005; 40:1288-97.
25. Greenberg D, Givon-Lavi N, Sharf AZ, Vardy D, Dagan R. The association between antibiotic use in the community and nasopha- ryngeal carriage of antibiotic-resistant Streptococcus pneumoniae in Bedouin children. Pediatr Infect Dis J 2008; 27:776-82.